| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |